Skip to content

NOTES Transvaginal Cholecystectomy and Appendectomy

NOTES Transvaginal Cholecystectomy and Appendectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00552162
Enrollment
6
Registered
2007-11-01
Start date
2008-06-30
Completion date
2018-01-01
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis, Gallbladder Diseases

Brief summary

Natural Orifice Translumenal Endoscopic Surgery (NOTES) is considered by many leading expert surgeons to be the next step in MIS (Minimally Invasive Surgery). This is a rapidly evolving area of preclinical research and several groups worldwide are developing this surgical approach together with industry support. In this new surgical technique, abdominal operations are performed using the oropharynx, rectum, or vagina as the ports of entry to the peritoneal cavity instead of incisions on the abdominal wall. NOTES offers all the advantages of minimally invasive surgery (MIS) and also completely eliminates trauma to the abdominal wall and the numerous complications of abdominal wall incisions. A NOTES procedure eliminates any visible scar and could also potentially reduce post operative pain due to the elimination of abdominal wall trauma. In this trial we intend to operate healthy women who need to undergo cholecystectomy or appendectomy. The operations will be performed through the vagina as the access port to the peritoneum and it will be monitored with laparoscopic vision for safety reasons.

Interventions

The gallbladder will be dissected free and will be removed through an incision in the vagina.

PROCEDURENOTES Transvaginal Appendectomy

The appendix will be dissected free and will be removed through an incision in the vagina.

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

for group #1 Transvaginal cholecystectomy: 1. Females between the ages of 18 and 50 2. Diagnosis of gallstone disease which requires cholecystectomy 3. ASA class 1

Exclusion criteria

for group #1 Transvaginal cholecystectomy: 1. Pregnant women 2. Morbidly obese patients (BMI \> 35) 3. Patients who are taking immunosuppressive medications and/or immunocompromised 4. Patients with severe medical comorbidities will be excluded. 5. Patients with a presumed gallbladder polyps, mass or tumor 6. Patients with a history of prior open abdominal or transvaginal surgery. 7. Patients with a prior history of peritoneal or vaginal trauma 8. Patients with a history of ectopic pregnancy, pelvic inflammatory disease, or severe endometriosis 9. Patients with known common bile duct stones 10. Patients on blood thinners or aspirin or abnormal blood coagulation tests Inclusion Criteria for group #2 Transvaginal appendectomy: 1. Clinical diagnosis of appendicitis 2. Emergency room evaluation within 36 hours of the onset of pain 3. ASA Classification

Design outcomes

Primary

MeasureTime frame
TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL APPROACH TO MINIMALLY INVASIVE SURGICAL TECHNIQUEScontinuous

Secondary

MeasureTime frame
TO ASSESS PAIN ASSOCIATED WITH TRANSVAGINAL APPROACHcontinuous

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026